Skip to content

Lucid Diagnostics LUCD Amortization of capitalized software and acquired intangible assets

Amortization of capitalized software and acquired intangible assets at other companies

Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
Quest Diagnostics logo
Quest DiagnosticsDGX
Labcorp Holdings logo
Labcorp HoldingsLH
Opko Health logo
Opko HealthOPK

Other financials

Income statement

See full
Revenue$1.3M+51.7%
Gross profit-$369.0K+49.0%
Operating income-$12.1M+3.0%
Net income-$13.9M+48.3%
EPS (diluted)-$0.10+60.0%

Balance sheet

See full
Cash & equivalents$27.9M+10.6%
Total debt$1.6M-35.1%
Total equity$4.0M+174%
Total assets$34.1M+3.9%

Cash flow

See full
Operating cash flow-$12.1M+2.9%
CapEx$215.0K+131%
Free cash flow-$12.3M+1.9%

Valuation

See full
Market cap$204.13M+58.5%
Enterprise value$177.85M+78.0%
P/S39.8×+10.2×

Profitability

See full
Gross margin-66.8%
Operating margin-959.6%-133pp
Net margin-876.7%-254pp
FCF margin-1,099.6%

Returns & leverage

See full
Return on equity-710.6%
Debt / equity0.4×
Current ratio1.1×+0.3×

Where this comes from

Reported directly by Lucid Diagnostics in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The official record: Lucid Diagnostics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lucid Diagnostics's amortization of capitalized software and acquired intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lucid Diagnostics's amortization of capitalized software and acquired intangible assets?
Lucid Diagnostics (LUCD) reported amortization of capitalized software and acquired intangible assets of $105K in Q1 2026.
How has Lucid Diagnostics's amortization of capitalized software and acquired intangible assets changed year-over-year?
Lucid Diagnostics's amortization of capitalized software and acquired intangible assets decreased by 0.0% year-over-year, from $105K to $105K.
What is the long-term trend for Lucid Diagnostics's amortization of capitalized software and acquired intangible assets?
Over 3 years (2022 to 2025), Lucid Diagnostics's amortization of capitalized software and acquired intangible assets has grown at a -36.6% compound annual growth rate (CAGR), from $1.65M to $420K.